COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry

Simple item page
dc.contributor.authorJose, Jerin
dc.contributor.authorTierney, Elif Seda Selamet
dc.contributor.authorHarahsheh, Ashraf S.
dc.contributor.authorDahdah, Nagib
dc.contributor.authorRaghuveer, Geetha
dc.contributor.authorFriedman, Kevin G.
dc.contributor.authorKhoury, Michael
dc.contributor.authorHicar, Mark D.
dc.contributor.authorMerves, Shae A.
dc.contributor.authorDallaire, Frederic
dc.contributor.authorFarid, Pedrom
dc.contributor.authorManlhiot, Cedric
dc.contributor.authorRuneckles, Kyle
dc.contributor.authorMisra, Nilanjana
dc.contributor.authorPortman, Michael
dc.contributor.authorBallweg, Jean A.
dc.contributor.authorLee, Simon
dc.contributor.authorJain, Supriya S.
dc.contributor.authorHarris, Tyler H.
dc.contributor.authorSzmuszkovicz, Jacqueline R.
dc.contributor.authorOrr, William
dc.contributor.authorLarios, Guillermo
dc.contributor.authorMcCrindle, Brian W.
dc.date.accessioned2025-01-20T20:17:29Z
dc.date.available2025-01-20T20:17:29Z
dc.date.issued2023
dc.description.abstractTo determine clinical differences for children with complete Kawasaki disease (KD) with and without evidence of preceding SARS-CoV-2 infection. From January 2020, contemporaneous patients with complete KD criteria were classified as either SARS-CoV-2 positive (KDCOVID+; confirmed household exposure, positive PCR and/or serology) or SARS-CoV-2 negative (KDCOVID-; negative testing and no exposure) and compared. Of 744 patients in the International Kawasaki Disease Registry, 52 were KDCOVID- and 61 were KDCOVID+. KDCOVID+ patients were older (median 5.5 vs. 3.7 years; p < 0.001), and all additionally met diagnostic criteria for multisystem inflammatory syndrome in children (MIS-C). They were more likely to have abdominal pain (60% vs. 35%; p = 0.008) and headache (38% vs. 10%; p < 0.001) and had significantly higher CRP, troponin, and BUN/creatinine, and lower hemoglobin, platelets, and lymphocytes. KDCOVID+ patients were more likely to have shock (41% vs. 6%; p < 0.001), ICU admission (62% vs. 10%; p < 0.001), lower left ventricular ejection fraction (mean lowest LVEF 53% vs. 60%; p < 0.001), and to have received inotropic support (60% vs. 10%; p < 0.001). Both groups received IVIG (2 doses in 22% vs. 18%; p = 0.63), but KDCOVID+ were more likely to have received steroids (85% vs. 35%; p < 0.001) and anakinra (60% vs. 10%; p = 0.002). KDCOVID- patients were more likely to have medium/large coronary artery aneurysms (CAA, 12% vs. 0%; p = 0.01). KDCOVID+ patients differ from KDCOVID-, have more severe disease, and greater evidence of myocardial involvement and cardiovascular dysfunction rather than CAA. These patients may be a distinct KD phenotype in the presence of a prevalent specific trigger.
dc.fuente.origenWOS
dc.identifier.doi10.1007/s00246-023-03109-w
dc.identifier.eissn1432-1971
dc.identifier.issn0172-0643
dc.identifier.urihttps://doi.org/10.1007/s00246-023-03109-w
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/92400
dc.identifier.wosidWOS:000931684900001
dc.issue.numero6
dc.language.isoen
dc.pagina.final1381
dc.pagina.inicio1373
dc.revistaPediatric cardiology
dc.rightsacceso restringido
dc.subjectKawasaki
dc.subjectCOVID-19
dc.subjectMIS-C
dc.subjectSARS-CoV-2
dc.subjectMIS-C with KD phenotype
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleCOVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry
dc.typeartículo
dc.volumen44
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas